YANGON----Plans are underway to produce 10 million of Myancopharm COVID-19 vaccines and then the Myancopharm vaccines firstly will be distributed to the Ministry of Health starting in April, according to the Information Team of the State Administration Council (SAC).

The SAC reported that Myanmar launched commercially production of Myancopharm COVID vaccines on March 10th and the Ministry of Industry will be manufacturing 10 million of Myancopharm COVID-19 vaccines for 2021-22 and 2022-2023 fiscal years. Moreover, the Myancopharm vaccines will be distributed to the Ministry of Health.

Currently,  a ceremony to test trial and to introduce Myancopharm COVID-19 vaccines will be held on March 23rd, according to the SAC.

Myanmar Pharmaceutical Industry (MPI) under the ministry took measures in July 2021 in collaboration with Sinopharm CNBG from China to produce a vaccine domestically. As MPI has infrastructure to produce anti-venoms and other vaccines, it is also in a position to produce a Covid vaccine, CNBG said in its reply quoted by the state-run newspaper The Mirror Daily.  

A none-disclosure agreement was signed in September 2021.

Moreover, two Chinese experts visited Myanmar, handed over production technology, gave training and supervised production process, the newspaper reported.

A vial of Myancopharm Covid vaccine can cover five doses.